1,3-Bis(carboxymethyl)-1H-imidazolium is a third-generation bisphosphonate anti-osteoporosis drug, which is mainly used for the treatment of osteoporosis, hypercalcemia and bone-related diseases caused by malignant tumors.It is a new type of bisphosphonic acid drug, which contains two phosphonic acid groups, and the compound is extremely polar. in injection products.
1,3-Bis(carboxymethyl)-1H-imidazolium is a pharmaceutical intermediate, which is mainly used as an impurity control in the process of pharmaceutical research and development, and can be used as a standard reference for analysis.
